Published in Int J Nanomedicine on July 13, 2015
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res (1995) 12.09
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm (2000) 4.68
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother (2004) 2.71
Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm (2001) 2.34
Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J Control Release (2002) 1.69
Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm (2006) 1.63
Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev (2007) 1.61
Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm (2006) 1.59
Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm (2002) 1.40
Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci (2008) 1.22
Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci (2008) 1.15
In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods. Altern Lab Anim (2001) 1.09
Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm (2005) 1.08
Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech (2008) 1.02
A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm (2008) 1.01
SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm (2010) 1.01
What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev (2007) 0.99
Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm (2008) 0.99
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm (2008) 0.98
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm (2009) 0.94
Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm (2004) 0.94
Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci (2004) 0.94
Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS PharmSciTech (2009) 0.88
Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull (2008) 0.88
Multivariate analysis of physicochemical characteristics of lipid based nanoemulsifying cilostazol--quality by design. Colloids Surf B Biointerfaces (2013) 0.86
Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Clin Pharmacokinet (1999) 0.86
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS PharmSciTech (2009) 0.84
Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. J Pharm Pharm Sci (2011) 0.83
Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci (2007) 0.83
In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration. Int J Pharm (2014) 0.82
Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur J Pharm Sci (2009) 0.82
Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke. Intern Med (2013) 0.81
Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm (2004) 0.80